PCN124 BUDGET IMPACT ANALYSIS OF IMMUNOTHERAPY AS SECOND-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AT MEXICO´S NATIONAL INSTITUTE OF CANCER
Abstract
Authors
F. Barrón-Barrón A.A. Meneses-García L.M. Rivera J. de la Garza-Salazar A.F. Cardona O.G. Arrieta F. Chávez Millan D. Palafox Torres J.Á. Paladio Hernández